Weiwei Rui

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Preoperative MR elastography for characterizing aggressive vascular phenotypes in hepatocellular carcinoma.

Preoperative MR elastography for characterizing aggressive vascular phenotypes in hepatocellular carcinoma.

Journal: European journal of radiology

Published: May 17, 2026

Discovery and Characterization of Benzamide Derivatives as Highly Potent SUCNR1 Antagonists for Cancer Immunotherapy.

Discovery and Characterization of Benzamide Derivatives as Highly Potent SUCNR1 Antagonists for Cancer Immunotherapy.

Journal: Journal of medicinal chemistry

Published: May 08, 2026

Corrigendum to "performance of the VENTANA FOLR1 assay for folate receptor alpha: Real-world evidence from 313 Chinese participants" pathology - research and practice 279 (2026) 156359.

Corrigendum to "performance of the VENTANA FOLR1 assay for folate receptor alpha: Real-world evidence from 313 Chinese participants" pathology - research and practice 279 (2026) 156359.

Journal: Pathology, research and practice

Published: February 27, 2026

Case Report: Synchronous primary lung and thyroid cancers - management informed by multimodal imaging and pathologic correlation.

Case Report: Synchronous primary lung and thyroid cancers - management informed by multimodal imaging and pathologic correlation.

Journal: Frontiers in oncology

Published: December 29, 2025

Occult Hypercalcemia Unmasked: Insights From Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Syndrome Associated With a Gastrointestinal Lymphoma.

Occult Hypercalcemia Unmasked: Insights From Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Syndrome Associated With a Gastrointestinal Lymphoma.

Journal: Cureus

Published: October 23, 2025

Performance of the VENTANA FOLR1 Assay for folate receptor alpha: Real-world evidence from 313 Chinese participants.

Performance of the VENTANA FOLR1 Assay for folate receptor alpha: Real-world evidence from 313 Chinese participants.

Journal: Pathology, research and practice

Published: October 09, 2025

Targeting EP2/EP4-driven expansion of suppressive VSIG4high macrophages overcomes immunotherapy resistance in colorectal cancer.

Targeting EP2/EP4-driven expansion of suppressive VSIG4high macrophages overcomes immunotherapy resistance in colorectal cancer.

Journal: Cell reports

Published: September 13, 2025

Diagnostic efficacy and subgroup heterogeneity of SHOX2, RASSF1A, Septin9, and HOXA9 methylation in pleural effusion lymphoma.

Diagnostic efficacy and subgroup heterogeneity of SHOX2, RASSF1A, Septin9, and HOXA9 methylation in pleural effusion lymphoma.

Journal: Clinical epigenetics

Published: April 12, 2025

Author Correction: The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer.

Author Correction: The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer.

Journal: Nature immunology

Published: March 11, 2025

Preoperative Multifrequency MR Elastography for Stratifying Wnt/β-Catenin Pathway and Microvascular Invasion Phenotypes in Hepatocellular Carcinoma.

Preoperative Multifrequency MR Elastography for Stratifying Wnt/β-Catenin Pathway and Microvascular Invasion Phenotypes in Hepatocellular Carcinoma.

Journal: Journal of magnetic resonance imaging : JMRI

Published: February 16, 2025

Discovery of a Highly Potent Oxysterol Receptor GPR183 Antagonist Bearing the Benzo[d]thiazole Structural Motif for the Treatment of Inflammatory Bowel Disease (IBD).

Discovery of a Highly Potent Oxysterol Receptor GPR183 Antagonist Bearing the Benzo[d]thiazole Structural Motif for the Treatment of Inflammatory Bowel Disease (IBD).

Journal: Journal of medicinal chemistry

Published: February 28, 2024

The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer.

The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer.

Journal: Nature immunology

Published: February 15, 2024

Showing 1-12 of 27

Last Updated: 09/26/2026